17th Annual International Atrial Fibrillation Symposium
Seaport Hotel & Conference Center
1 Seaport Lane Бостън, MA MA 02210, United States (800) 440-3318
Boston, Massachusetts
The Boston AF Symposium was initiated in 1995 in response to the growing epidemic of atrial fibrillation and to highlight the early work being done on the feasibility of catheter ablation as a potential treatment option of the future.  In sixteen years, this meeting has evolved into a major scientific forum at which health care professionals have a unique opportunity to learn about all aspects of atrial fibrillation research and therapeutics directly from many of the most innovative investigators in the field. This intensive and highly focused three-day symposium brings together leading medical scientists from all over the world to teach, discuss and debate in a highly interactive environment the most current advances in the field of atrial fibrillation. 

The primary objective of the meeting is to provide attendees with an in-depth view of the current state of the art in the field of atrial fibrillation in a scholarly and collegial atmosphere.  In addition to its world-class international faculty, the meeting employs some of the most advanced teaching tools including satellite and pre-recorded case demonstrations and audience response systems.  Each year, we strive for a fresh and innovative approach to communicating the most up-to-date basic, translational and clinical science as they evolve toward a more complete understanding of the pathophysiology of atrial fibrillation with the primary goal of developing safer and more effective strategies for the treatment of this common arrhythmia.


Schedule of Presentations:

Thursday, January 12, 2012
07:30:00 Introduction and Overview of the Symposium Jeremy Ruskin
07:50:00 Molecular Basis of Atrial Remodeling and AF Perpetuation Jose Jalife
08:15:00 Obesity and Obstructive Apnea – Mechanisms of AF Promotion in Experimental Models Stanley Nattel
08:40:00 Genetics of AF: How Will We Translate GWAS Findings to Clinical Practice? Patrick Ellinor
09:05:00 New Directions in Antiarrhythmic Drug Therapy for AF Charles Antzelevitch
09:30:00 Best Basic Science Papers on AF for 2011 Jose Jalife
10:35:00 Best Clinical Science Papers on AF for 2011 Eric Prystowsky
11:00:00 Antiarrhythmic Use in Clinical Practice: Focus on Clinical Trials of Dronedarone Peter Kowey
11:25:00 Difficult Cases in AF Management – Antiarrhythmic Drugs, Anticoagulation, and Clinical Decision Making
11:30:00 Panel and Audience Discussion Jeremy Ruskin, John Camm, Hans Kottkamp, Kevin Heist, Peter Kowey, Eric Prystowsky, Albert Waldo
14:10:00 Role of Yoga and Stress Reduction Techniques in the Management of AF
14:35:00 Satellite Case Presentations | Massachusetts General Hospital, Boston, MA Centro Cardiologico Monzino, Milan, Italy Jeremy Ruskin, Moussa Mansour, Kevin Heist, Claudio Tondo
14:40:00 Pre-Recorded Case Presentations
14:50:00 William Beaumont Hospital, Royal Oak, MI David Haines
14:55:00 Central Hospital University of Bordeaux, Bordeaux, France Pierre Jais
15:00:00 Allgemeines Krankenhaus St. Georg, Hamburg, Germany
15:05:00 Hospital Universitario La Paz, Madrid, Spain
15:10:00 University of California San Diego, San Diego, CA Sanjiv Narayan
18:00:00 ADJOURN
Friday, January 13, 2012
07:30:00 Morning Scientific Session
07:30:00 Pulmonary Vein Reconnection | (All talks 20 min) Francis Marchlinski
07:50:00 Physiology of Lesion Formation During AF Ablation: Lessons Learned from MRI Nassir F. Marrouche
08:05:00 Basic Mechanisms and Pharmacologic Strategies to Unmask PV Reconnection Stanley Nattel
08:20:00 Role of Adenosine, Waiting Time, Early Monitoring, Antiarrhythmic Drugs and Steroids in Detecting and Modifying PV Reconnection Hans Kottkamp
08:40:00 Techniques to Improve Catheter Contact During AF Ablation Francis Marchlinski
09:05:00 Durability of PV Isolation with Different Energy Sources Vivek Y. Reddy
09:35:00 Panel and Audience Discussion (30 minutes): All Faculty
10:05:00 Rotors in Atrial Fibrillation – From Cell to Bedside | (All talks 20 min)
10:10:00 Physiology of Rotors in Experimental Models of Atrial Fibrillation
10:25:00 Electrical Rotors and Focal Beats – Relationship to CFAE and Role in Causing Human AF Sanjiv Narayan
10:40:00 Noninvasive Mapping of Human AF – Insights into Mechanisms Pierre Jais
11:10:00 Is There Sufficient Evidence for Rotors in Human AF? Shih-Ann Chen
11:55:00 Panel and Audience Discussion (30 minutes): All Faculty
12:00:00 AF Guidelines and Regulatory Issues | (All talks 20 min) Douglas L. Packer
12:05:00 2012 HRS Consensus Document on AF Ablation Hugh Calkins
12:20:00 Update on AF Registries and Surveys – How are Patients with AF Managed in Clinical Practice? John Camm
12:40:00 FDA Regulatory Update Randall Brockman
14:25:00 Stroke Prevention in Atrial Fibrillation | (All talks 20 min unless otherwise specified) Daniel Singer
14:30:00 Overview of Stroke Prevention in Atrial Fibrillation 2012 Daniel Singer
14:35:00 Pharmacologic Therapies
15:05:00 AVERROES and ARISTOTLE Trials – Design, Results, Clinical Implications, Limitations and Comparison with RE-LY and ROCKET-AF (30 minutes) Christopher Granger
15:25:00 Practical Implications of Trial Data and Clinical Experience with Novel Anticoagulants Jeffrey Weitz
15:50:00 Management of Anticoagulation for AF Ablation
15:50:00 Management of Anticoagulation for cCardioversion and Device Implantation in Patients with AF Michael Gold
16:25:00 Nonpharmacologic Therapies
16:45:00 Catheter-Based Approaches to Stroke Prevention Zoltan Turi
17:05:00 Surgical Management of the Left Atrial Appendage
17:25:00 Silent AF and Stroke Risk | Asymptomatic Device-Detected AF and Risk of Stroke: TRENDS, ASSERT AND IMPACT Trials John Camm
17:40:00 Asymptomatic Intracranial Thromboembolic Events after AF Ablation Thomas Arentz
18:00:00 Panel and Audience Discussion | All Faculty (30 minutes)
18:30:00 ADJOURN
Saturday, January 14, 2012
07:30:00 Clinical Trials in AF Ablation – 2012 Update (30 min) Hugh Calkins
08:05:00 Long Term Outcomes of Catheter Ablation for PAF – Nature of Recurrences and Management David J. Wilber
08:30:00 Late Recurrences After AF Ablation – Insights from Implantable Monitoring Gerhard Hindricks
08:55:00 Should PVI Be Performed in Patients Who Present with Atrial Flutter?
09:20:00 Management of Persistent AF | (All talks 20 min) Pierre Jais
09:25:00 Pulmonary Vein Isolation Alone for Persistent AF Francis Marchlinski
09:45:00 Stepwise Substrate Modification for Persistent AF Pierre Jais
10:05:00 Conversion to NSR During Catheter Ablation of Persistent AF – Predictors and Predictive Value Moussa Mansour
10:20:00 Five Year Outcome of Catheter Ablation for Longstanding Persistent AF
10:40:00 Catheter Ablation in Patients with Prosthetic Heart Valves Andrea Natale
11:05:00 Surgical Management of Persistent AF Ralph Damiano
11:35:00 Lesion Monitoring During AF Ablation | (All Talks 10 minutes) Moussa Mansour
11:40:00 Contact Force Sensing Larry Chinitz
12:05:00 Ultrasound Pierre Jais
12:25:00 Direct Visualization Moussa Mansour
12:30:00 Tissue Temperature
12:35:00 MRI Nassir F. Marrouche
12:40:00 Linear Lesions in AF Ablation – 2012 Update
13:05:00 LUNCH
13:50:00 Rapid, High-Resolution Automated Catheter Mapping in Patients with Complex Left Atrial Tachycardia After Catheter and Surgical Ablation of Atrial Fibrillation Hiroshi Nakagawa
14:15:00 Complications of AF Ablation – 2012 Update Douglas L. Packer
14:40:00 How to Set Up an AF Ablation Program (30 min)
15:15:00 Challenging Cases in AF Ablation: Panel and Audience Discussion David J. Wilber
15:25:00 Case Presentations (10 min each) Pierre Jais
15:35:00 Case Presentations (10 min each) Moussa Mansour
15:45:00 Case Presentations (10 min each) Francis Marchlinski
15:55:00 Case Presentations (10 min each) Andrea Natale
16:05:00 Case Presentations (10 min each) Douglas L. Packer
16:15:00 Case Presentations (10 min each) Vivek Y. Reddy
16:25:00 Case Presentations (10 min each) David J. Wilber
17:00:00 ADJOURN
3D Tissue Models
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.